Tenovus Cancer Care joined forces with the Life Sciences Research Network Wales to showcase the very latest advances in the fight against cancer.
Experts from across the UK met at the Life Sciences Hub at Cardiff Bay to discuss the very latest advancements in cancer research to an audience which included PhD students funded by Tenovus Cancer Care, key supporters of the charity and Deputy Health Minister Vaughan Gething AM.
Among the speakers were Hugh Griffiths, whose work with Professor Chris McGuigan has led to the development of Acelarin, which is helping to control the spread of solid tumours in cancer patients.
Professor McGuigan, Chair of Life Sciences Research Network Wales and the Life Sciences Hub Wales, and inventor of Acelarin, said: “At the National Research Network, we are proud to work with Tenovus in bringing better drugs forward to improve the treatment of cancer in patients across Wales, and beyond,”
Each year Tenovus Cancer Care invests nearly £0.5 million across 20 PhD projects making us one of the largest supporters of early career researchers and scientists in Wales. We are also pleased to announce that starting this October we will be investing a further £900,000 in 10 PhD studentships based at Cardiff, Swansea and Bangor Universities.
This year Tenovus Cancer Care has partnered with the Life Sciences Research Network (LSRN) to jointly support a PhD studentship in cancer drug development.
These studentships span a breadth of cancer research areas, including drug development, immunotherapy, cancer genetics and prostate cancer treatment choices.
Dr Ian Lewis, Director of Research at Tenovus Cancer Care, said: “Wales is at the forefront of some really exciting developments in cancer research. We are really proud to be working with the Life Sciences Research Network to support this PhD studentship, which will help us develop new drugs to combat cancer.”
Deputy Health Minister Vaughan Gething AM added: “We have made real progress in improving cancer care in Wales – more people than ever now survive cancer, even though more people are being diagnosed.”
“The work of Tenovus is a fantastic example of how the third sector and NHS Wales work together to meet the needs of patients. My hope is such ongoing collaboration can continue to support society’s wider efforts to tackle the burden of cancer on individuals and the health service.”